Friday, October 1st, 2021

Programme timing is based on PDT (Vancouver, Canada) Time.

Track 1
4:30 AM - 6:00 AM

NASS Section on Spinal Cord Injury and The International Spinal Cord Society (ISCoS) Presents: Complex Spinal Trauma and Spinal Cord Injury Management

R Saigal (NASS), Y Lu (NASS), M G Fehlings ISCoS/NASS), H Chhabra (ISCoS)
7:00 AM - 8:30 AM

How to measure patient's beliefs about their spinal cord injury during first rehabilitation and apply the results.

M Post, J Duff, H Kuiper, C van Leeuwen
09:00 AM – 10:30 AM
Instructional Course:

Measuring quality of life after SCI: Key findings from a validation study of the International Spinal Cord Injury Quality of Life Basic Data Set (SCI-QoLBDS)

J Coker, D Tate, M Post, E Rohn
11:00 AM – 12:30 PM

Knowledge translation in spinal cord injury (SCI) research: gaps and bridges

K Anderson, G Ahren, A Vecchio
12:45 PM – 1:45 PM
Plenary # 3 - ISRT Lecture

Targeting metabolism and signalling for repair and regeneration after nervous system injuries

S DI Giovanni
2:00 PM – 3:30 PM

Prevention of falls and spinal cord injury: a joint ISCoS / ASIA / WHO workshop

J-G Previnaire, B Lee, Y Dionyssiotis, A Krassioukov, D Meddings
4:00 PM – 5:30 PM
Instructional Course:

Taking a closer look at peer support services in Canada

S Sweet, R Shaw, K Best, C McBride
7:00 PM – 8:30 PM
Instructional Course:

Infection-related myelopathy: The common and uncommon across the globe

M Linke, H Chhabra, F Theron
9:00 PM– 10:00 PM
Plenary # 4 – Anthony DiMarco Lecture

Neural control of respiratory muscles and methods to improve their function after cervical spinal cord injury.

J Butler
Track 2
• #315 Remodelling of urothelial barrier after SCI: are the derivatives of poloyunsaturated fatty acids (PUFAs) involved? Preliminary results on a preclinic model;
M-A Perrouin-Verbe
• #267 Vitamin D status and supplementation during acute rehabilitation of patients with a SCI – a prospective observation study
J L Flueck
• #137 Proteomic and bioinformatics analyses of plasma from SCI neurological improvers and non-improvers
G M B Harrington
• #165 Applying a novel multivariate biomarker to determine cardiovascular disease risk in persons with chronic SCI
C Cirnigliaro
• #240 Evaluating advanced MRI biomarkers for axon and myelin loss after human traumatic spinal cord injury
S Morris
• #428 Development of an implantable optical sensor to monitor spinal cord hemodynamics and oxygenation from bench to bedside
S Askari
• #300 Role of PET scan in management of secondaries of the spine – a retrospective study
H S Chhabra
• #237 Longitudinal changes in cardiometabolic risk factors in subacute traumatic and non-traumatic SCI: evidence from the multicenter SCI cohort in Switzerland (SwiSCI)
M Glisic
• #110 Traumatic and non-traumatic spinal cord injuries: comparison of neurological and functional outcomes
G Scivoletto
• #394 Hospitalization experience in patients with non-traumatic spinal cord dysfunction: a population-based study
S Magalhaes
• #364 A new approach to ambulant patients with cauda equina syndrome. A model of inpatient specialist spinal rehabilitation on the London SCI Centre, UK
W Goodison
• #268 Significant reduction of urinary incontinence episodes in patients with neurogenic detrusor overactivity treated with abobotulinum toxin A (aboBoNT-A): pooled results of a phase III CONTENT program
P Denys
• #256 External validation confirms validity of a simple model to predict bowel outcome after traumatic SCI
C Pavese
• #324 Effects of transanal irrigation (TAI) on large bowel motility and transit in patients with neurogenic bowel dysfunction by colonic ultrasound and scintigraphy
G Frasca
• #408 The “Nottwil Standard” – development and implementation of an ICF-based clinical standard assessment during post-acute rehabilitation after newly acquired SCI
A Scheel-Sailer
• #339 Are early clinical manifestations of spasticity associated with long-term functional outcome following a traumatic SCI?: a retrospective cohort study
A Richard-denis
• #182 Clinical characteristics, risk factors and outcomes of COVID-10 in spinal cord injuries population: the Stoke Mandeville first wave experience
W Ahmed
• #464 Effect of lactobacillus casei shirota in preventing antibiotic associated diarrhoea including C Diff infection in patients with SCI: a multicentre randomized, double-blinded, placebo-controlled trial
S Wong
• #323 Trauma-induced perturbations of serological markers
L Bourguignon
• #314 Symptoms suggestive of UTIs among intermittent urinary catheter users; a retrospective, real-world analysis of a longitudinal patient database
E Chartier-Kastler
• #187 Wearable movement sensors in spinal cord injury: barriers and possibilities
M Vos
• #14 Sex as a key determinant of the management and outcomes of individuals with acute traumatic SCI: a series of propensity-score matched cohort studies
J Furlan
• #346 Utilising the ICF Core Data Sets to achieve population health surveillance in SCI
R. Marshall
• #150 Spinal cord tissue oxygen guided treatment for patients with acute, severe traumatic SCIs
R Visagan
• #132 Review of VHA SCI/D Eberhart COVID Risk Assessment Tool (SEC-RAT) development, implementation and outcomes during the COVID-19 pandemic
A. Eberhart
• #234 Establishing the world’s first international poly-user spinal cord injury biobank
A Velenosi
• #222 Prescription opioid use for pain in individuals with spinal cord injury: Scoping review
J Shoup
• #144 Improving disabilities awareness in undergraduate medical education: experiences and recommendations for a course on providing healthcare for people living with physical challenges from people with lived experiences
V Patel
• #457 Neuromodulation for control of gait using combined deep brain stimulation and epidural stimulation in a translational large animal model of SCI
B Noga
• #131 Orthostatic changes in blood pressure and cerebral blood flow velocity in newly injured patients with traumatic SCI
J Wecht
• #181 Prospective evaluation of the sensitivity and specificity of the Spinal Cord Injury Pressure Sore Onset Risk Screening (SCI-PreSORS) instrument during inpatient SCI rehabilitation
A Burns
• #238 Quality over quantity: the quality of physical activity participation experiences is a stronger predictor of quality of life than time spent participating in physical activity
K Martin Ginis
• #445 Using geographically-explicit ecological momentary assessment to understand the role of environmental factors in community participation for people with SCI: results of a pilot study from the US
A Botticello
• #308 Conceptualizing symptom clusters using proxy variables in SCI symptom science research
L Graves
• #332 Measuring behaviour change techniques delivery and receipt in a physical activity behavioural intervention for adults with a spinal cord injury
F Hoekstra
• #379 How does participant posture influence laser evoked potentials?
L Linde
• #347 Correlations between % body fat evaluated by dual energy x-ray absorptiometry and anthropometric measurements in Thai disables with chronic traumatic SCI
S Pattanakuhar
• #142 Cost-utility analysis of a combination of transcranial direct current stimulation and virtual illusion for neuropathic pain for adults with spinal cord injury in Canada
M Xi
• #418 Do Rehabilitation Programs in India and Neighbouring Countries Facilitate Independent Living and Community Reintegration/Participation in Persons with Spinal Cord Injury?
J Jesudas
• #407 Effects of active arm-cycling versus passive leg exercise interventions on left ventricular structure, function, and mechanics of individuals with chronic motor-complete spinal cord injury: An exploratory randomized clinical trial
S Balthazaar
ALL DAY (24-hours)
Poster Viewing
Poster Hall
Virtual Exhibition
Chat Rooms
World Clock

Copyright © ISCoS. All Rights Reserved

Designed & Developed By: ASL